Literature DB >> 26718339

Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Elzbieta Jacek1, Kevin S Tang1, Lars Komorowski2, Mary Ajamian1, Christian Probst2, Brian Stevenson3, Gary P Wormser4, Adriana R Marques5, Armin Alaedini6.   

Abstract

Most immunogenic proteins of Borrelia burgdorferi, the causative agent of Lyme disease, are known or expected to contain multiple B cell epitopes. However, the kinetics of the development of human B cell responses toward the various epitopes of individual proteins during the course of Lyme disease has not been examined. Using the highly immunogenic VlsE as a model Ag, we investigated the evolution of humoral immune responses toward its immunodominant sequences in 90 patients with a range of early to late manifestations of Lyme disease. The results demonstrate the existence of asynchronous, independently developing, Ab responses against the two major immunogenic regions of the VlsE molecule in the human host. Despite their strong immunogenicity, the target epitopes were inaccessible to Abs on intact spirochetes, suggesting a lack of direct immunoprotective effect. These observations document the association of immune reactivity toward specific VlsE sequences with different phases of Lyme disease, demonstrating the potential use of detailed epitope mapping of Ags for staging of the infection, and offer insights regarding the pathogen's possible immune evasion mechanisms.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718339      PMCID: PMC4722499          DOI: 10.4049/jimmunol.1501861

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Case definitions for public health surveillance.

Authors:  M Wharton; T L Chorba; R L Vogt; D L Morse; J W Buehler
Journal:  MMWR Recomm Rep       Date:  1990-10-19

3.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

Review 4.  In the clinic. Lyme disease.

Authors:  Linden T Hu
Journal:  Ann Intern Med       Date:  2012-08-07       Impact factor: 25.391

5.  Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.

Authors:  J R Zhang; J M Hardham; A G Barbour; S J Norris
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

6.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

7.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

8.  Transcriptional regulation of the Borrelia burgdorferi antigenically variable VlsE surface protein.

Authors:  Tomasz Bykowski; Kelly Babb; Kate von Lackum; Sean P Riley; Steven J Norris; Brian Stevenson
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

Review 9.  Lyme disease: a multisystem infection that affects the nervous system.

Authors:  John J Halperin
Journal:  Continuum (Minneap Minn)       Date:  2012-12

10.  Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Authors:  R V Fleming; A R Marques; M S Klempner; C H Schmid; L G Dally; D S Martin; M T Philipp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-08       Impact factor: 3.267

View more
  10 in total

1.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

2.  Identifying Vancomycin as an Effective Antibiotic for Killing Borrelia burgdorferi.

Authors:  Xiaoqian Wu; Bijaya Sharma; Samantha Niles; Kathleen O'Connor; Rebecca Schilling; Nicole Matluck; Anthony D'Onofrio; Linden T Hu; Kim Lewis
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

3.  A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

Authors:  Siddarth Arumugam; Samiksha Nayak; Taylor Williams; Francesco Serra di Santa Maria; Mariana Soares Guedes; Rodrigo Cotrim Chaves; Vincent Linder; Adriana R Marques; Elizabeth J Horn; Susan J Wong; Samuel K Sia; Maria Gomes-Solecki
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

4.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

Review 5.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

6.  Reply to Naktin.

Authors:  Melanie Uhde; Mary Ajamian; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 20.999

Review 7.  Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi.

Authors:  Brandee L Stone; Catherine A Brissette
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

8.  Detection of a Low Level and Heterogeneous B Cell Immune Response in Peripheral Blood of Acute Borreliosis Patients With High Throughput Sequencing.

Authors:  Josiane Kirpach; Alessia Colone; Jean-Philippe Bürckert; William J Faison; Axel R S X Dubois; Regina Sinner; Anna L Reye; Claude P Muller
Journal:  Front Immunol       Date:  2019-05-16       Impact factor: 7.561

9.  Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format.

Authors:  Jack Reifert; Kathy Kamath; Joel Bozekowski; Ewa Lis; Elizabeth J Horn; Dane Granger; Elitza S Theel; John Shon; Jaymie R Sawyer; Patrick S Daugherty
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

10.  Identification of Borrelia protein candidates in mouse skin for potential diagnosis of disseminated Lyme borreliosis.

Authors:  Antoine Grillon; Benoît Westermann; Paola Cantero; Benoît Jaulhac; Maarten J Voordouw; Delphine Kapps; Elody Collin; Cathy Barthel; Laurence Ehret-Sabatier; Nathalie Boulanger
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.